Huanqiu Li

Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Corrigendum to "Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation" [Eur. J. Med. Chem. 316 (2026) 119068].

Corrigendum to "Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation" [Eur. J. Med. Chem. 316 (2026) 119068].

Journal: European journal of medicinal chemistry

Published: July 03, 2026

Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation.

Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation.

Journal: European journal of medicinal chemistry

Published: May 14, 2026

LSD1 inhibitors for anticancer therapy: an updated patent review (2022-2025).

LSD1 inhibitors for anticancer therapy: an updated patent review (2022-2025).

Journal: Expert opinion on therapeutic patents

Published: February 20, 2026

Targeting P2Y14 Receptor in Inflammatory and Metabolic Diseases: From Pathophysiology to Therapeutic Inhibitors.

Targeting P2Y14 Receptor in Inflammatory and Metabolic Diseases: From Pathophysiology to Therapeutic Inhibitors.

Journal: Medicinal research reviews

Published: January 29, 2026

Discovery of Novel P2Y14R Inhibitors for Ameliorating Liver Fibrosis by Suppressing Hepatic Stellate Cell Activation.

Discovery of Novel P2Y14R Inhibitors for Ameliorating Liver Fibrosis by Suppressing Hepatic Stellate Cell Activation.

Journal: Journal of medicinal chemistry

Published: November 03, 2025

Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer.

Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: August 11, 2025

Machine Learning Applied in Small Molecule Drug Discovery: Models, Strategies, and Future Prospects.

Machine Learning Applied in Small Molecule Drug Discovery: Models, Strategies, and Future Prospects.

Journal: Current topics in medicinal chemistry

Published: July 17, 2025

Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment.

Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment.

Journal: Journal of medicinal chemistry

Published: July 03, 2025

The Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge.

The Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge.

Journal: Neurology international

Published: May 20, 2025

Small-molecule inhibitors in psoriasis: medicinal chemistry insights.

Small-molecule inhibitors in psoriasis: medicinal chemistry insights.

Journal: Expert opinion on drug discovery

Published: May 17, 2025

Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors.

Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors.

Journal: Pharmacology & therapeutics

Published: August 13, 2024

Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches.

Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches.

Journal: Chemical biology & drug design

Published: May 06, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026